The post Unmasking Facial Melanosis: A Prospective Clinico-Dermoscopic Study appeared first on MoleMax Systems.

This guide is an overview: it covers the evaluation framework and several lesion types that don’t yet have a dedicated deep-dive on this site  junctional nevus vs. melanoma, melanosis, subungual melanoma, and Spitz naevus  and links out to our fuller guides on basal cell carcinoma, acral lesions, the 7-point checklist, and mole mapping where those already exist. 

What Skin Lesion Evaluation Involves 

Good skin lesion evaluation combines the clinical picture  history, change over time, and patient risk factors with a magnified dermoscopic view. Dermoscopy adds a second layer of information: pigment network, vessels, colours, and specific structures that correlate with particular diagnoses. The goal is not to replace histology but to decide, with far greater accuracy, which lesions can be reassured, which need monitoring, and which require biopsy. 

A Structured Approach to Reading Lesions 

Experienced clinicians rarely assess a lesion at random. A common method is the two-step approach: first decide whether a lesion is melanocytic or non-melanocytic, then apply the relevant criteria for that category. This is followed by pattern analysis weighing symmetry, the regularity of the pigment network, the number of colours, and any melanoma-specific structures. Working through a lesion in this order reduces the chance of anchoring on a single feature and missing the bigger picture. 

Junctional Nevus vs. Melanoma 

One of the most common diagnostic questions is junctional nevus vs. melanoma. 

The overlap between the two is exactly why structured scoring matters. Applying a framework such as the 7-Point Checklist for Melanoma helps quantify suspicious features rather than relying on impression alone, and digital monitoring adds the dimension of change over time often the deciding factor for a borderline lesion that looks stable on a single visit. 

Melanosis and Pigmented Lesions 

Melanosis and other flat pigmented lesions present their own evaluation challenge, particularly on sun-damaged skin and mucosal surfaces where benign pigmentation and early melanoma can look alike. Dermoscopy helps by revealing whether the pigment follows a regular, structured pattern or an irregular, chaotic one, and whether specific worrying structures are present. 

Documenting these lesions is especially valuable, because subtle change is often the earliest sign that a stable-looking pigmented area needs review. A baseline image gives the clinician something concrete to compare against at the next visit, rather than relying on memory. 

Subungual Melanoma: Reading the Nail 

Few findings cause more anxiety than a pigmented streak in the nail. Subungual melanoma is rare but serious, and it is frequently mistaken for benign melanonychia or a simple haematoma. Dermoscopy of the nail assesses the colour, width, spacing, and regularity of the pigmented band, along with any pigment extending onto the surrounding skin Hutchinson’s sign, an important warning sign. 

A widely used screening framework, the ABCDEF rule for subungual melanoma, adds nail-specific criteria age, band breadth and border irregularity, change, digit involved, extension onto skin, and family history — to the general ABCDE approach. Any irregular, broadening, or multicoloured band warrants specialist referral. Cancer Council Australia emphasises that early detection is decisive for melanoma outcomes, and the nail is one site where delayed diagnosis is unfortunately common. When in doubt, referral and biopsy are the safe path. 

Spitz Naevus and Other Look-Alikes 

Some benign lesions are notorious for imitating melanoma. Spitz naevus, most common in children and young adults, can show a striking starburst or globular pattern that overlaps with melanoma-specific features. In adults especially, a lesion with spitzoid features is usually excised rather than monitored, because the dermoscopic distinction from melanoma is not reliable enough to justify watchful waiting. Knowing these traps prevents both false reassurance and unnecessary alarm. 

Colours Under Dermoscopy and What They Mean 

Colour is one of the most information-rich signals in skin lesion evaluation, because it effectively reports the depth of the pigment. 

A key rule of thumb: the more colours present in a single lesion, the greater the concern. A uniformly brown lesion is usually reassuring, whereas a lesion showing three or more colours  particularly blue-white or grey  deserves closer scrutiny and, often, biopsy. 

Benign Mimics Worth Knowing 

Not every alarming-looking lesion is dangerous. Seborrhoeic keratoses, for example, are extremely common benign lesions that can appear dark and irregular yet show reassuring dermoscopic features  milia-like cysts, comedo-like openings, and a brain-like surface. Recognising these benign patterns confidently is as important as spotting malignant ones: it prevents unnecessary excisions and reassures patients. 

Common Pitfalls to Avoid 

• Relying on a single feature rather than the overall pattern. 

• Examining a lesion under too much pressure, blanching its vessels and losing the vascular information. 

• Under-calling amelanotic and nodular melanomas, which lack the classic pigment cues  any firm, growing, or bleeding lesion deserves suspicion regardless of colour. 

• Failing to document a borderline lesion, which removes the option of comparison later  arguably the most valuable tool a clinician has. 

Combining the ABCDE Rule with Dermoscopy 

The naked-eye ABCDE rule  Asymmetry, Border irregularity, Colour variation, Diameter over 6mm, and Evolution  remains a useful first filter, especially for patients performing self-examination. Dermoscopy builds on it rather than replacing it: where ABCDE flags a lesion as potentially concerning, dermoscopy interrogates the same lesion at a structural level, confirming or downgrading the suspicion. The two work best together  ABCDE catches the clinician’s attention, and dermoscopy refines the decision that follows. 

The “E” for evolution deserves particular emphasis, because change over time is the most reliable single indicator of malignancy, and it is precisely what digital documentation captures better than memory ever could. 

Basal Cell Carcinoma Dermoscopy 

Basal cell carcinoma dermoscopy is one of the clearest success stories for the technique  arborising vessels, blue-grey ovoid nests, leaf-like areas, and spoke-wheel structures make BCC one of the more recognisable tumours under the dermatoscope, and help distinguish it from benign pink lesions such as intradermal naevi or sebaceous hyperplasia. 

For the full feature set and how subtype patterns guide treatment choice, see Clinical and Dermoscopic Characterization of Mixed-Type Basal Cell Carcinoma. 

Acral Lesions: Palms and Soles 

Lesions on the palms and soles follow their own dermoscopic rules because of the ridged skin found there: benign acral naevi typically show pigment along the furrows (the parallel-furrow pattern), whereas acral melanoma more often shows pigment on the ridges (the parallel-ridge pattern). 

For the evidence behind this distinction and the fuller set of acral patterns, see Diagnostic Accuracy of Dermoscopic Features in Acral Lentiginous Melanoma and Dermoscopic Features of Acral Palmoplantar Nevi. Any irregular or broad pigmentation on these sites still warrants careful assessment regardless of pattern. 

Documentation and Monitoring Over Time 

Across every lesion type above, the single biggest advantage of modern practice is the ability to compare images over time. A digital dermoscopy system such as the MoleMax HD, paired with a quality DermLite dermatoscope, lets clinicians capture a lesion today and re-examine the exact same site months later. 

For how total body photography and change tracking fit together, see Mole Mapping Technology; for how AI-assisted analysis adds a further layer of change detection, see AI Skin Cancer Detection System. 

Building Dermoscopy into Routine Practice 

The clinics that get the most from dermoscopy are those that make it routine rather than occasional. Photographing lesions consistently, storing images in a searchable record, and reviewing them at each visit turns a one-off examination into genuine longitudinal care  more than any single feature, that habit drives earlier detection and better outcomes. 

Skill also grows with reference and repetition. Comparing uncertain lesions against curated image libraries such as Dermoscopedia and DermNet steadily sharpens pattern recognition, and combining that study with a consistent imaging workflow is the fastest way for a clinic to raise the quality of its skin lesion evaluation across every practitioner on the team. 

Bring Structure to Your Skin Checks 

The clearest way to see how digital dermoscopy fits your workflow is a live walkthrough. Book a free 15-minute MoleMax demo and our specialist team will show you high-resolution capture, lesion tracking, side-by-side comparison, and structured reporting on real cases  and answer any questions specific to your practice. 

The post Skin Lesion Evaluation with Dermoscopy: A Clinical Guide  appeared first on MoleMax Systems.

The post The Evaluation of Clinical and Dermatoscopic Features of Scalp Nevi in Adults appeared first on MoleMax Systems.

The demand for objective, quantifiable hair loss assessment has grown significantly as treatment options have expanded and patients expect measurable evidence of treatment progress. TrichoScan Software addresses this need directly, providing dermatologists, trichologists, and hair restoration clinics with a computer-assisted digital hair analysis platform that delivers reproducible, evidence-based clinical data. This article provides a comprehensive guide to TrichoScan technology, its clinical applications, and how it supports modern dermatology practice. 

What Is TrichoScan? 

TrichoScan is a computer-assisted digital hair analysis software system designed for objective measurement of key hair growth parameters. It uses high-resolution scalp images captured through digital imaging systems to automatically identify, count, and measure individual hair follicles and shafts across a defined scalp area. 

Unlike traditional visual assessment or manual trichogram methods, TrichoScan provides quantitative clinical data that is consistent, reproducible, and directly comparable across multiple patient visits. This makes it particularly valuable for monitoring treatment response over time, where small but clinically significant changes in hair density or growth rate must be detected reliably. 

Modern versions of TrichoScan incorporate AI-assisted image analysis to improve detection accuracy, reduce operator variability, and increase workflow efficiency. Available through MoleMax Systems, TrichoScan integrates into existing digital dermatology workflows alongside skin imaging and dermoscopy solutions. 

How Does TrichoScan Work? 

TrichoScan follows a structured, repeatable assessment process that ensures consistent results across patient visits and clinical operators. 

Step 1: Select the Assessment Area 

A standardised assessment area on the scalp is selected and marked to ensure the same region is imaged at each subsequent visit. Standardisation of the assessment site is critical for accurate longitudinal comparison. 

Step 2: Prepare the Scalp Area 

The selected area is prepared by clipping hair to a uniform length. This standardises hair shaft length across the assessment area and ensures accurate automated counting and measurement. 

Step 3: Capture High-Resolution Images 

High-resolution scalp images are captured using a digital imaging system such as the MoleMax HD, which provides the image quality required for accurate automated analysis. 

Step 4: Automated Hair Analysis 

TrichoScan’s automated image analysis algorithms process the captured images, identifying and measuring individual hair follicles and shafts. The software distinguishes between terminal and vellus hairs, identifies hair growth phases, and calculates key measurement parameters across the assessment area. 

Step 5: Generate Quantitative Reports 

TrichoScan generates standardised clinical reports containing objective measurement data. These reports are stored in the patient record and used for direct comparison at subsequent visits, supporting evidence-based clinical decision-making and patient communication. 

Key measurements generated by TrichoScan include: 

• Hair density (hairs per cm²) 

• Hair diameter (micrometres) 

• Hair growth rate (mm per day) 

• Anagen to telogen ratio 

• Terminal to vellus hair ratio 

• Cumulative hair thickness index 

Key Features of TrichoScan 

AI-Powered Image Analysis: TrichoScan uses AI-assisted algorithms to automatically detect and measure hair follicles and shafts, reducing operator variability and improving detection accuracy across diverse scalp types and hair colours. 

Automated Hair Counting: Manual hair counting is eliminated. TrichoScan automatically counts hairs within the defined assessment area, producing consistent counts that are unaffected by clinician fatigue or observer bias. 

Hair Density Measurement: Hair density is measured objectively in hairs per square centimetre, providing a clinically meaningful baseline and enabling precise monitoring of density changes in response to treatment. 

Longitudinal Treatment Tracking: Patient images and measurements are stored in a structured digital record. At each follow-up visit, new measurements are automatically compared with baseline data, generating clear visual and quantitative evidence of treatment response. 

Standardised Reporting: TrichoScan generates standardised reports suitable for clinical records, patient communication, and research documentation. Reports include measurement summaries, comparative data across visits, and visual image overlays. 

Reproducible Clinical Results: Standardised image capture and automated analysis ensure that results are reproducible regardless of which clinician performs the assessment, supporting consistency in multi-practitioner settings. 

Digital Patient Records: All images, measurements, and reports are stored digitally within the patient record, supporting efficient retrieval, longitudinal comparison, and audit-ready documentation. 

Clinical Applications of TrichoScan 

TrichoScan supports assessment and monitoring across a broad range of hair loss conditions and clinical scenarios. 

Androgenetic Alopecia 

Androgenetic alopecia is the most common cause of hair loss in both men and women. TrichoScan provides objective measurement of miniaturisation progression, terminal-to-vellus hair ratio, and density changes, enabling earlier detection of disease progression and more accurate monitoring of treatment response to medications such as finasteride and minoxidil. 

Alopecia Areata 

In alopecia areata, TrichoScan supports monitoring of regrowth patterns within affected patches, assessment of new follicular activity, and quantification of treatment response to corticosteroids, immunotherapy, and newer biological agents. 

Telogen Effluvium 

Telogen effluvium presents with diffuse shedding that is difficult to quantify objectively. TrichoScan’s anagen-to-telogen ratio measurement provides a direct, reproducible index of the proportion of follicles in the shedding phase, supporting both diagnosis and monitoring of recovery. 

Hair Transplant Planning and Monitoring 

Hair transplant surgeons use TrichoScan to assess donor area density before surgery, plan graft numbers with precision, and monitor transplanted follicle growth and survival rates post-procedure. Objective density measurements at baseline and follow-up provide legally and clinically defensible documentation of outcomes. 

Post-Treatment Monitoring 

For all hair loss conditions, TrichoScan provides the objective evidence needed to assess treatment effectiveness over time. Changes in hair density, diameter, and growth rate that are imperceptible to visual examination are reliably detected and documented through repeated TrichoScan assessments. 

Clinical Research Studies 

TrichoScan’s standardised, reproducible measurement methodology makes it suitable for use in clinical trials and research studies evaluating new hair loss treatments. Its AI-assisted analysis reduces inter-observer variability, improving the reliability of research data. 

Benefits of TrichoScan for Dermatology Clinics 

Objective Diagnosis Support: TrichoScan replaces subjective visual assessment with quantitative clinical data, improving diagnostic confidence and supporting evidence-based clinical decision-making. 

Improved Patient Communication: Visual reports showing before-and-after images and quantitative measurement comparisons are powerful tools for patient education and treatment adherence. Patients who can see objective evidence of improvement are more likely to continue treatment. 

Quantifiable Treatment Outcomes: The ability to demonstrate measurable treatment outcomes differentiates clinics that use TrichoScan from those relying on visual assessment alone. This supports stronger patient outcomes, better retention, and enhanced clinic reputation. 

Time-Saving Clinical Workflow: Automated image analysis and report generation reduce the time required per assessment compared with manual counting methods. This supports higher patient throughput without compromising assessment quality. 

Enhanced Patient Confidence: Patients presenting with hair loss concerns are often anxious and uncertain about treatment prospects. Objective baseline measurements and clear progress reports build trust and confidence in clinical management. 

Comprehensive Documentation: Standardised digital records support clinical governance, audit requirements, medico-legal documentation, and continuity of care across clinical team members. 

TrichoScan vs Traditional Hair Assessment Methods 

Traditional visual scalp examination remains the most widely used initial assessment approach but provides no quantitative data and is highly dependent on individual clinician experience. The hair pull test gives a gross indication of active shedding but provides no density or growth rate data. 

The traditional trichogram involves manually plucking hairs for microscopic analysis, which is uncomfortable for patients, provides limited density information, and is difficult to reproduce accurately across different operators or time points. 

TrichoScan Software addresses all of these limitations through automated image analysis, standardised assessment protocols, and comprehensive digital reporting. It was specifically developed to provide a more reproducible and less subjective hair assessment process, and its clinical utility has been validated across multiple published research studies. 

Why Dermatology Clinics Choose TrichoScan 

Clinics that adopt TrichoScan report improvements across multiple dimensions of their hair loss assessment workflow. Evidence-based measurement data supports stronger clinical decision-making, clearer patient communication, and more defensible documentation of treatment outcomes. 

The ability to track treatment response objectively over months and years is particularly valuable in conditions like androgenetic alopecia, where changes are gradual and difficult to perceive without quantitative measurement. TrichoScan makes these changes visible and documentable, supporting both clinical and commercial outcomes for the practice. 

Integration with digital skin imaging solutions from MoleMax Systems allows clinics to combine hair analysis with broader dermatological imaging capabilities, creating a comprehensive digital dermatology workflow within a single practice environment. 

Why Buy TrichoScan from MoleMax Systems? 

MoleMax Systems, a division of Macquarie Medical Systems, has supported dermatology clinics, hair restoration practices, and medical research institutions with advanced digital imaging solutions for decades. As an established provider of dermatology imaging software and hardware, MoleMax offers TrichoScan with full implementation support, clinical training, and ongoing technical assistance.

The MoleMax team understands the clinical environment in which TrichoScan is used and provides support tailored to the specific needs of dermatology practices, trichology clinics, and hair transplant centres. Combined with hardware solutions such as the MoleMax HD digital imaging system, TrichoScan becomes part of a fully integrated digital dermatology and hair analysis platform. 

Purchasing TrichoScan through MoleMax Systems ensures access to Australian healthcare expertise, local warranty and support, and a team with direct experience in clinical dermatology and hair analysis technology. 

The post TrichoScan: Digital Hair Analysis for Modern Dermatology  appeared first on MoleMax Systems.

The post One Clue, Two Outcomes: Benign vs Malignant Through Dermoscopy appeared first on MoleMax Systems.